Healthcare provider profile · identity verified

Craig A Grimes, MD

Internal Medicine · LYNN, MA · NPI 1245286012

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	635	179
Lisinopril	Lisinopril	506	140
Amlodipine Besylate	Amlodipine Besylate	403	113
Simvastatin	Simvastatin	297	84
Omeprazole	Omeprazole	256	77
Metoprolol Succinate	Metoprolol Succinate	230	67
Levothyroxine Sodium	Levothyroxine Sodium	225	59
Gabapentin	Gabapentin	203	32
Losartan Potassium	Losartan Potassium	196	64
Metformin Hcl	Metformin Hcl	178	48
Furosemide	Furosemide	174	46
Lorazepam	Lorazepam	150	45
Allopurinol	Allopurinol	145	42
Tamsulosin Hcl	Tamsulosin Hcl	145	37
Rosuvastatin Calcium	Rosuvastatin Calcium	144	45
Alprazolam	Alprazolam	131	27
Hydrochlorothiazide	Hydrochlorothiazide	110	33
Sertraline Hcl	Sertraline Hcl	108	34
Albuterol Sulfate Hfa	Albuterol Sulfate	102	34
Eliquis	Apixaban	94	21
Atenolol	Atenolol	89	22
Trazodone Hcl	Trazodone Hcl	86	23
Ezetimibe	Ezetimibe	82	22
Tramadol Hcl	Tramadol Hcl	81	15
Citalopram Hbr	Citalopram Hydrobromide	76	15
Pantoprazole Sodium	Pantoprazole Sodium	76	22
Jardiance	Empagliflozin	75	16
Zolpidem Tartrate	Zolpidem Tartrate	75	19
Glipizide	Glipizide	70	20
Fluticasone Propionate	Fluticasone Propionate	67	25
Oxycodone Hcl	Oxycodone Hcl	60	13
Donepezil Hcl	Donepezil Hcl	54	13
Metformin Hcl Er	Metformin Hcl	53	17
Finasteride	Finasteride	51	14
Famotidine	Famotidine	47	16
Xarelto	Rivaroxaban	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Valsartan	Valsartan	39	12
Ventolin Hfa	Albuterol Sulfate	39	11
Spironolactone	Spironolactone	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	12
Potassium Chloride	Potassium Chloride	37	suppressed
Synthroid	Levothyroxine Sodium	37	14
Prednisone	Prednisone	36	26
Valacyclovir	Valacyclovir Hcl	36	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	20
Metoprolol Tartrate	Metoprolol Tartrate	34	11
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Ibuprofen	Ibuprofen	29	12
Montelukast Sodium	Montelukast Sodium	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	13
Carvedilol	Carvedilol	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Diazepam	Diazepam	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	15
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Oxycontin	Oxycodone Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Azithromycin	Azithromycin	19	18
Meclizine Hcl	Meclizine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Amoxicillin	Amoxicillin	17	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	13
Torsemide	Torsemide	17	suppressed
Cephalexin	Cephalexin	16	13
Doxycycline Monohydrate	Doxycycline Monohydrate	16	13
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Triazolam	Triazolam	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Colchicine	Colchicine	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Naproxen	Naproxen	13	suppressed
Ozempic	Semaglutide	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error